89243223CNE000030↗
American Centrifuge Operating, LLC received this contract from Idaho Operations Office, Department of Energy: $332.04M obligated so far for nuclear reactors. Its period of performance ended 2026-10-15; options could extend it to 2028-06-30.
Key facts · data as of Oct 25, 2026
- Recipient
- American Centrifuge Operating, LLC
- Awarding agency
- Department of Energy
- Contracting office
- Idaho Operations Office (892432)
- Obligated to date
- $332.04M
- Potential value
- $1.11B
- Ends
- 2026-10-15
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 25, 2026.
Cite this page: SpendQuery, Award 89243223CNE000030, data as of Oct 25, 2026, https://spendquery.com/award?id=CONT_AWD_89243223CNE000030_8900_-NONE-_-NONE-
American Centrifuge Operating, LLC: all federal awards · Department of Energy: spending · Idaho Operations Office: what it buys · The follow-on: recompete brief
HIGH ASSAY LOW ENRICHED URANIUM (HALEU) CASCADE DEMO COMPLETION AND EXTENDED PRODUCTION
Obligated to date$332.04M29 actions
Current value$332.42Mwith options exercised
Potential value$1.11Bif every option is used
Period2022-11-30 → 2026-10-15up to 2028-06-30 with options
Up for re-bid: ends 2026-10-15. Recompete brief →
What it is
- Product or service
- Nuclear Reactors (PSC 4470)
- Industry
- Nuclear Electric Power Generation (NAICS 221113)
- Contracting office
- Idaho Operations Office (892432)
- Competition
- Full and open competition · 2 offers received
- Pricing
- Cost sharing
- How it was bought
- Standalone contract
- Solicitation
- 89243222RNE000026
- Where the work is
- Pike, OH · district OH-02
- Funding law
- Other emergency or disaster supplementals
Obligations by fiscal year
FY2023$33.35M
FY2024$85.00M
FY2025$197.82M
FY2026$15.88M
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Every action
29 actions since 2022-11-30. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-09-30 | P00028 | Change order | $0 | THE PURPOSE OF THIS AMENDMENT IS TO: 1. EXTEND OPTION PERIOD 1B 15 DAYS 2. AUTHORIZE CHANGE ORDERS UNDER CLIN 0006 |
| 2026-06-30 | P00027 | Option exercised | $15.00M | THE PURPOSE OF THIS AMENDMENT TO THE CONTRACT IS TO: EXERCISE THE MODIFIED CLIN 0008 (OPTION PERIOD 1B), WHICH IS 3-MONTHS CASCADE MAINTENANCE AND STORE SNM, WITH NO HALEU PRODUCTION. |
| 2026-01-12 | P00026 | Change order | $875.3K | THE PURPOSE OF THIS AMENDMENT IS TO APPROVE AND FUND MULTIPLE CHANGE ORDERS. |
| 2025-12-08 | P00025 | Change order | $0 | THE PURPOSE OF THIS AMENDMENT TO THE CONTRACT IS TO EXTEND THE PHASE 2 PERIOD OF PERFORMANCE FROM OCTOBER 31, 2025, TO JANUARY 31, 2026. |
| 2025-08-20 | P00024 | Change order | $1.56M | THE PURPOSE OF THIS AMENDMENT TO THE CONTRACT IS TO AUTHORIZE MULTIPLE CHANGE ORDERS, APPROVE A NEW CBA AGREEMENT, AND EXTEND THE PHASE 2 PERIOD OF PERFORMANCE. |
| 2025-06-18 | P00023 | Funding only | $108.00M | INCREMENTALLY FUND CLIN 0002 IN THE AMOUNT OF $11,049.88. INCREMENTALLY FUND CLIN 0003 IN THE AMOUNT OF $107,993,746.00. |
| 2025-06-17 | P00022 | Option exercised | $0 | MODIFY AND EXERCISE OPTION PERIOD BY SPLITTING IT UP BETWEEN TWO CLINS, FROM A 3-YEAR OPTION PERIOD UNDER ONE CLIN TO A ONE AND TWO-YEAR OPTION PERIOD UNDER TWO SEPARATE CLINS. |
| 2025-06-13 | P00021 | Funding only | $8.24M | AUTHORIZE MOVING SCOPE FROM CLIN 003 TO CLIN 002 TO PURCHASE THE LEU FEED CYLINDER THEY NEED FOR PHASE 3 PRODUCTION IN NOVEMBER 2025, PROCURING ADDITIONAL WASTE STORAGE, AND INCREMENTAL FUNDING FOR CLIN 002 IN THE AMOUNT OF $8,238,455.24. |
| 2025-06-03 | P00020 | Funding only | $8.53M | 1. AUTHORIZE CONTINUED PERFORMANCE OF PHASE 2 ACTIVITIES THROUGH JUNE 30, 2025, AND AUTHORIZE LIMITED FUNDING IN THE AMOUNT OF $8,530,292.00 2. PROVIDE INCREMENTAL FUNDING UNDER CLIN 0002 IN THE AMOUNT OF $8,530,292.00 |
| 2025-05-05 | P00019 | Administrative change | $7.60M | 1. AUTHORIZE CONTINUED PERFORMANCE OF PHASE 2 ACTIVITIES THROUGH MAY 31, 2025. 2.PROVIDE INCREMENTAL FUNDING UNDER CLIN 0002 IN THE AMOUNT OF $7,600,000, CHANGING THE TOTAL OBLIGATIONS FOR CLIN 0002 FROM $144,722,536 TO $152,322,536. |
| 2025-03-31 | P00018 | Administrative change | $15.69M | THE PURPOSE OF THIS AMENDMENT TO THE CONTRACT IS TO: 1.EXTEND THE DEFINITIZATION DEADLINE DETAILED IN MODIFICATION 017 OF THIS CONTRACT FROM MARCH 31, 2025 TO APRIL 30, 2025. 2.AUTHORIZE CONTINUED PERFORMANCE OF PHASE 2 ACTIVITIES THROUGH 4/30/25 |
| 2025-02-19 | P00017 | Administrative change | $0 | 1.EXTEND THE DEFINITIZATION DEADLINE DETAILED IN MODIFICATION 015 OF THIS CONTRACT FROM FEBRUARY 28, 2025, TO MARCH 31, 2025. 2.AUTHORIZE CONTINUED PERFORMANCE OF PHASE 2 ACTIVITIES THROUGH MARCH 31, 2025 WITHIN THE EXISTING COST CEILING |
| 2025-01-10 | P00016 | Funding only | $14.21M | THE PURPOSE OF THIS MODIFICATION IS TO: 1. PROVIDE INCREMENTAL FUNDING TO CLIN 0002 IN THE AMOUNT OF $14,211,340.00, CHANGING THE TOTAL OBLIGATION FROM $114,817,188.00 TO $129,028,528.00. |
| 2024-12-31 | P00015 | Administrative change | $0 | THE PURPOSE OF THIS MODIFICATION IS TO: EXTEND THE DEFINITIZATION DEADLINE DETAILED IN MODIFICATION 013 OF THIS CONTRACT FROM DECEMBER 31, 2024, TO FEBRUARY 28, 2025, AND AUTHORIZE AN ADDITIONAL LIMITED COST CEILING INCREASE OF $13,489,552.00(NO FEE |
| 2024-12-19 | P00014 | Change order | $9.88M | THE PURPOSE OF THIS MODIFICATION IS TO ADD INCREMENTAL FUNDING AND APPROVE FOUR CHANGE ORDERS |
| 2024-11-05 | P00013 | Change order | $24.11M | 1.EXTEND THE PHASE 2 PERIOD OF PERFORMANCE END DATE FROM NOVEMBER 6, 2024, TO JUNE 30, 2025 |
| 2024-11-04 | P00012 | Change order definitized | $0 | THE PURPOSE OF THIS AMENDMENT TO: 1. AUTHORIZE THE PURCHASE AND INSTALLATION OF TWO REPLACEMENT PERSONNEL CONTAMINATION MONITORS(PCMS) 2. AUTHORIZE THE PURCHASE OF TEN 5B CYLINDERS 3. AMEND THE CONTRACT TO ADD OPERATIONS SHIFT COORDINATORS(OSC) |
| 2024-08-14 | P00011 | Change order | $29.25M | THE PURPOSE OF THIS AMENDMENT TO: 1.PROVIDE INCREMENTAL FUNDING TO CLIN 0002 IN THE AMOUNT OF $28,906,490.90 2.PROVIDE INCREMENTAL FUNDING TO CLIN 0006 IN THE AMOUNT OF $345,521.00 3.AUTHORIZE THE INSTALLATION OF ONE REPLACEMENT X-6000 TRANSFORMER |
| 2024-06-08 | P00010 | Funding only | -$5.46M | THE PURPOSE OF THIS AMENDMENT TO THE CONTRACT IS TO: 1. DE-OBLIGATE CLIN 0002 FUNDING IN THE AMOUNT OF -$5,463,616.00 IN ORDER TO COMPLETE THE INTERNAL DOE ACCOUNTING ADJUSTMENT REFERENCED IN MOD 009, CHANGING THE TOTAL OBLIGATION FOR CLIN 0002 FR |
| 2024-05-21 | P00009 | Funding only | $20.63M | 1. PROVIDE INCREMENTAL FUNDING TO CLIN 0002 IN THE AMOUNT OF $20,627,096.00, CHANGING THE TOTAL OBLIGATION FROM $39,080,875.23 TO $59,707,971.23. NOTE: A SUBSEQUENT AMENDMENT WILL IMMEDIATELY FOLLOW IN ORDER TO DE-OBLIGATE $5,463,616.00 IN FUNDS |
| 2024-04-29 | P00008 | Funding only | $9.80M | PROVIDE INCREMENTAL FUNDING TO CLIN 0002 IN THE AMOUNT OF $9,799,429.60, CHANGING THE TOTAL OBLIGATION FROM $29,281,445.63 TO 39,080,875.23. |
| 2024-04-04 | P00007 | Funding only | $4.76M | PROVIDE INCREMENTAL FUNDING TO CLIN 0002 IN THE AMOUNT OF $4,756,181.53, CHANGING THE TOTAL OBLIGATION FROM $24,525,264.10 TO $29,281,445.63. |
| 2023-12-27 | P00006 | Funding only | $20.57M | 1.OBLIGATE FUNDING TO CLIN 0001 FOR $770,016.87.00, CHANGING THE TOTAL OBLIGATION FROM $28,270,000.00 TO $29,040,016.87. 2.OBLIGATE FUNDING TO CLIN 0007 FOR $19,795,264.10, CHANGING THE TOTAL OBLIGATION FROM $4,730,000.00 TO $24,525,264.10. |
| 2023-10-19 | P00005 | Funding only | $5.46M | 1) OBLIGATE $901,128.00 TO CLIN 00006, CHANGING THE TOTAL OBLIGATION FROM $150,000.00 TO $1,051,128.00. 2) OBLIGATE $4,562,488.00 TO CLIN 00007, CHANGING THE TOTAL OBLIGATION FROM $200,000.00 TO $4,762,488.00. |
| 2023-09-29 | P00004 | Change order definitized | $350.0K | HIGH ASSAY LOW ENRICHED URANIUM (HALEU) CASCADE DEMO COMPLETION AND EXTENDED PRODUCTION 1.INCREMENTAL FUNDING IN THE AMOUNT OF $23,000,000. $3,730,000 GOING TO CLIN 0002 AND $19,270,000 GOING TO CLIN 0001. |
| 2023-04-03 | P00003 | Funding only | $23.00M | HIGH ASSAY LOW ENRICHED URANIUM (HALEU) CASCADE DEMO COMPLETION AND EXTENDED PRODUCTION 1.INCREMENTAL FUNDING IN THE AMOUNT OF $23,000,000. $3,730,000 GOING TO CLIN 0002 AND $19,270,000 GOING TO CLIN 0001. |
| 2023-03-21 | P00002 | Administrative change | $5.00M | 1.INCREMENTAL FUNDING IN THE AMOUNT OF $5,000,000. 2.UPDATE THE PERIOD OF PERFORMANCE START FROM 11/30/22 TO 12/01/22. 3.UPDATE CLAUSE 52.244-2 SUBCONTRACTS 4.APPROVE CLIN 2 ACTIVITIES IN CLIN 1 |
| 2023-01-19 | P00001 | Administrative change | $2.80M | HIGH ASSAY LOW ENRICHED URANIUM (HALEU) CASCADE DEMO COMPLETION AND EXTENDED PRODUCTION DE-OBLIGATE $2,203,879 FROM CLIN 0001 AND OBLIGATE $5,000,000 TO CLIN 0001. |
| 2022-11-30 | 0 | $2.20M | HIGH ASSAY LOW ENRICHED URANIUM (HALEU) CASCADE DEMO COMPLETION AND EXTENDED PRODUCTION |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-25). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗